T. Rowe Price Associates’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $748K | Buy |
44,531
+2,804
| +7% | +$47.1K | ﹤0.01% | 2111 |
|
|
2025
Q1 | $736K | Buy |
41,727
+6,114
| +17% | +$108K | ﹤0.01% | 2096 |
|
|
2024
Q4 | $866K | Buy |
35,613
+3,066
| +9% | +$74.6K | ﹤0.01% | 2023 |
|
|
2024
Q3 | $1.21M | Buy |
32,547
+426
| +1% | +$15.8K | ﹤0.01% | 1890 |
|
|
2024
Q2 | $1.53M | Buy |
32,121
+1,811
| +6% | +$86.3K | ﹤0.01% | 1696 |
|
|
2024
Q1 | $1.16M | Buy |
30,310
+1,813
| +6% | +$69.4K | ﹤0.01% | 1845 |
|
|
2023
Q4 | $890K | Buy |
28,497
+1,907
| +7% | +$59.6K | ﹤0.01% | 1920 |
|
|
2023
Q3 | $1.07M | Buy |
26,590
+1,876
| +8% | +$75.4K | ﹤0.01% | 1759 |
|
|
2023
Q2 | $1.3M | Buy |
24,714
+1,045
| +4% | +$55K | ﹤0.01% | 1664 |
|
|
2023
Q1 | $1.51M | Buy |
23,669
+572
| +2% | +$36.6K | ﹤0.01% | 1578 |
|
|
2022
Q4 | $1.12M | Buy |
23,097
+64
| +0.3% | +$3.11K | ﹤0.01% | 1712 |
|
|
2022
Q3 | $1.63M | Sell |
23,033
-626
| -3% | -$44.2K | ﹤0.01% | 1528 |
|
|
2022
Q2 | $1.68M | Buy |
23,659
+981
| +4% | +$69.6K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $1.81M | Buy |
22,678
+2,656
| +13% | +$212K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $1.83M | Sell |
20,022
-4,285
| -18% | -$391K | ﹤0.01% | 1753 |
|
|
2021
Q3 | $3.12M | Buy |
24,307
+3,625
| +18% | +$466K | ﹤0.01% | 1595 |
|
|
2021
Q2 | $3.15M | Sell |
20,682
-22,528
| -52% | -$3.44M | ﹤0.01% | 1600 |
|
|
2021
Q1 | $4.56M | Sell |
43,210
-26,898
| -38% | -$2.84M | ﹤0.01% | 1484 |
|
|
2020
Q4 | $5.55M | Buy |
70,108
+51,835
| +284% | +$4.11M | ﹤0.01% | 1426 |
|
|
2020
Q3 | $1.03M | Buy |
18,273
+14,626
| +401% | +$828K | ﹤0.01% | 1780 |
|
|
2020
Q2 | $224K | Buy |
+3,647
| New | +$224K | ﹤0.01% | 2332 |
|